Reason for request
Renewal of inclusion
Clinical Benefit
| Substantial |
the actual benefit of CERVARIX remains substantial only the Marketing Authorisation indications recommended by the HCSP in the current vaccination schedule. |
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
SXmBYZx4eqnEBAyQ
